Literature DB >> 9684777

A three-dimensional consideration of variant human fibrinogens.

S J Everse1, G Spraggon, R F Doolittle.   

Abstract

Recently reported X-ray structures for large core fragments derived from human fibrinogen and fibrin make it possible to correlate structural and functional anomalies of known genetic variants. Here we examine a variety of amino acid replacements previously reported for hereditary dysfibrinogenemias, most of which are associated with impaired fibrin polymerization. For many of these we have modeled in the mutant amino acid and considered the structural consequences. We have also examined the cases of a small deletion and a large insertion, as well as the impact of substitutions in the GPRPam ligand that was co-crystallized with fragment double-D.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9684777

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  5 in total

1.  Direct observation of the anchoring process during the adsorption of fibrinogen on a solid surface by force-spectroscopy mode atomic force microscopy.

Authors:  J Hemmerlé; S M Altmann; M Maaloum; J K Hörber; L Heinrich; J C Voegel; P Schaaf
Journal:  Proc Natl Acad Sci U S A       Date:  1999-06-08       Impact factor: 11.205

Review 2.  Structure and function of human fibrinogen inferred from dysfibrinogens.

Authors:  Michio Matsuda; Teruko Sugo
Journal:  Int J Hematol       Date:  2002-08       Impact factor: 2.490

Review 3.  Fibrin Formation, Structure and Properties.

Authors:  John W Weisel; Rustem I Litvinov
Journal:  Subcell Biochem       Date:  2017

4.  Interaction between extracellular matrix molecules and microbial pathogens: evidence for the missing link in autoimmunity with rheumatoid arthritis as a disease model.

Authors:  Nidhi Sofat; Robin Wait; Saralili D Robertson; Deborah L Baines; Emma H Baker
Journal:  Front Microbiol       Date:  2015-01-14       Impact factor: 5.640

5.  New circulating biomarkers for predicting cardiovascular death in healthy population.

Authors:  Olle Melander; Javier Modrego; Jose J Zamorano-León; Juana M Santos-Sancho; Vicente Lahera; Antonio J López-Farré
Journal:  J Cell Mol Med       Date:  2015-08-10       Impact factor: 5.310

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.